Curis, Inc.
Compounds and compositions for treating hematological disorders
Last updated:
Abstract:
The present invention provides methods of treating hematological disorders and solid malignant tumors, using substituted indazole compounds and pharmaceutically acceptable salts thereof. The compounds inhibit IRAK4 and BCL-2 kinases.
Status:
Grant
Type:
Utility
Filling date:
31 Oct 2018
Issue date:
1 Sep 2020